Datalogic S p A : Conference Call

FY 2022 Results

Conference Call

MARCH 10, 2023

Disclaimer

This document has been prepared by Datalogic S.p.A. (the "Company") for use during meetings with investors and financial analysts and is solely for information purposes. The information set out herein has not been verified by an independent audit company.

Neither the Company nor any of its subsidiaries, affiliates, branches, representative offices (the "Group"), as well as any of their directors, officers, employees, advisers or agents (the "Group Representatives") accepts any responsibility for/or makes any representation or warranty, express or implied, as to the accuracy, timeliness or completeness of the information set out herein or any other related information regarding the Group, whether written, oral or in visual or electronic form, transmitted or made available.

This document may contain forward-looking statements about the Company and/or the Group based on current expectations and opinions developed by the Company, as well as based on current plans, estimates, projections and projects of the Group. These forward-looking statements are subject to significant risks and uncertainties (many of which are outside the control of the Company and/or the Group) which could cause a material difference between forward-looking information and actual future results.

The information set out in this document is provided as of the date indicated herein. Except as required by applicable laws and regulations, the Company assumes no obligation to provide updates of any of the aforesaid forward-looking statements.

Under no circumstances shall the Group and/or any of the Group Representatives be held liable (for negligence or otherwise) for any loss or damage howsoever arising from any use of this document or its contents or otherwise in connection with the document or the aforesaid forward- looking statements.

This document does not constitute an offer to sell or a solicitation to buy or subscribe to Company shares and neither this entire document or a portion of it may constitute a recommendation to affect any transaction or to conclude any legal act of any kind whatsoever.

This document may not be reproduced or distributed, in whole or in part, by any person other than the Company.

By viewing and/or accepting a copy of this document, you agree to be bound by the foregoing limitations.

2

FY 2022 & Q4 2022 Results1

FY 2022 Results

REVENUES

€654.6

+9.5%

Q4 2022 Results

REVENUES

€178.1

+7.4%

GOM

€274.5

41.9%

(-1.2 pp)

GOM

€73.5

41.3%

+2.7 pp

Adj. EBITDA

€80.3

12.3%

(-2.0 pp)

Adj. EBITDA

€24.0

13.5%

+1.7 pp

€ m

NET RESULT

€ 30.1

4.6%

(-2.0 pp)

€ m

NET RESULT

€14.3

8.0%

+2.4 pp

Net Debt at €42.0M

1 The comparative results as of December 31, 2021 have been restated following the purchase price allocation (PPA) accounting of MD Group acquisition occurred in 2021, as required by the accounting standards IFRS 3 revised and IAS

1, including reclassifications to ensure results comparability.	3

FY 2022 Highlights: a progressive recovery of sales

and profitability

• Revenues growth nearly at double digit and sound recovery of profitability in 2H
• Improving performance across all main industries and geographies despite the complex scenario due to the shortage of components

• Gross Operating Margin at 41.9% thanks to price/mix discipline and product redesign, partially offsetting components' price headwinds
• R&D Cash Out at €64.6M, steady at around 10.0% on revenues, executing technological roadmap

• Positive price/mix in the year across main geographies and product lines
• Revenue from new products (vitality index) at 13.4% vs 12.5% in FY2021

• Adj EBITDA margin at 12.3% (13.5% in Q4, + 1.7 pps vs Q4 2021)
• Net Debt down at €42.0M, thanks to a strong operating cash generation in Q4, and despite a high Net Working Capitalresulting from cost inflation and high inventory levels attributable to shortages

4

Group Revenues by Geography

€m	FY 2022	FY 2021		Var %
Restated	1
EMEAI	354.9	334.5		6.1%
Americas	199.1	168.1		18.4%
APAC	100.6	95.2		5.6%
Total Datalogic	654.6	597.8		9.5%

% on Group Revenues

APAC 15.4%

EMEAI 54.2%

Americas 30.4%

• EMEAI: Group's first market up by 6.1% (+5.2% Net FX), led by UK & Nordics, Iberia, Italy and Benelux
• AMERICAS: Group's second-largest market leads the overall growth at +18.4% (+5.7% Net FX), across all the main industries
• APAC: +5.6% YoY, growth mainly driven by Japan (> 30% Net FX), and China

1 The comparative results as of December 31, 2021 have been restated following the purchase price allocation (PPA) accounting of MD Group acquisition occurred in 2021, as required by the accounting standards IFRS 3 revised and IAS

1, including reclassifications to ensure results comparability.	5